Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sonia Vallabh, Ph.D.

Co-Author

This page shows the publications co-authored by Sonia Vallabh and Eric Minikel.
Connection Strength

4.204
  1. Implications of new genetic risk factors in prion disease. Nat Rev Neurol. 2021 01; 17(1):5-6.
    View in: PubMed
    Score: 0.913
  2. Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints. Nucleic Acids Res. 2020 11 04; 48(19):10615-10631.
    View in: PubMed
    Score: 0.903
  3. Regional variability and genotypic and pharmacodynamic effects on PrP concentration in the CNS. JCI Insight. 2022 Mar 22; 7(6).
    View in: PubMed
    Score: 0.248
  4. Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass Spectrometry. Mol Cell Proteomics. 2019 Dec; 18(12):2388-2400.
    View in: PubMed
    Score: 0.225
  5. Multimodal small-molecule screening for human prion protein binders. J Biol Chem. 2020 09 25; 295(39):13516-13531.
    View in: PubMed
    Score: 0.222
  6. Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease. BMC Med. 2020 06 18; 18(1):140.
    View in: PubMed
    Score: 0.220
  7. Towards a treatment for genetic prion disease: trials and biomarkers. Lancet Neurol. 2020 04; 19(4):361-368.
    View in: PubMed
    Score: 0.216
  8. Characterization of the Prion Protein Binding Properties of Antisense Oligonucleotides. Biomolecules. 2019 12 18; 10(1).
    View in: PubMed
    Score: 0.212
  9. Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass Spectrometry. Mol Cell Proteomics. 2019 12; 18(12):2388-2400.
    View in: PubMed
    Score: 0.209
  10. Antisense oligonucleotides extend survival of prion-infected mice. JCI Insight. 2019 07 30; 5.
    View in: PubMed
    Score: 0.207
  11. Age at onset in genetic prion disease and the design of preventive clinical trials. Neurology. 2019 07 09; 93(2):e125-e134.
    View in: PubMed
    Score: 0.205
  12. Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development. Proc Natl Acad Sci U S A. 2019 04 16; 116(16):7793-7798.
    View in: PubMed
    Score: 0.202
  13. Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med. 2016 Jan 20; 8(322):322ra9.
    View in: PubMed
    Score: 0.162
  14. Novel quaternary structures of the human prion protein globular domain. Biochimie. 2021 Dec; 191:118-125.
    View in: PubMed
    Score: 0.060
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.